ciglitazone and 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid
ciglitazone has been researched along with 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bissonnette, RP; Chen, YE; Leander, M; Major, EO; Royal, W | 1 |
Other Studies
1 other study(ies) available for ciglitazone and 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid
Article | Year |
---|---|
Nuclear receptor activation and interaction with morphine.
Topics: Astrocytes; Benzoates; Cell Line; Cell Line, Tumor; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation; Humans; Lymphoma; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phytohemagglutinins; Retinoid X Receptors; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydronaphthalenes; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2004 |